HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis.

Abstract
A preterm newborn had transient neonatal myasthenia gravis and was mechanically ventilated for 9 days. In addition to the usual supportive care, she was treated with neostigmine and underwent two exchange transfusions. High-dose intravenous immunoglobulin therapy (2 gm/kg) was used for the first time in transient neonatal myasthenia gravis to the best of our knowledge. The clinical and laboratory responses are presented.
AuthorsH Bassan, B Muhlbaur, A Tomer, Z Spirer
JournalPediatric neurology (Pediatr Neurol) Vol. 18 Issue 2 Pg. 181-3 (Feb 1998) ISSN: 0887-8994 [Print] United States
PMID9535308 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantibodies
  • Immunoglobulins, Intravenous
  • Receptors, Cholinergic
Topics
  • Acute Disease
  • Autoantibodies (blood)
  • Female
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Infant, Newborn
  • Myasthenia Gravis (immunology, therapy)
  • Receptors, Cholinergic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: